Tectonic Therapeutic focuses on therapeutic biologics targeting GPCRs through its GEODe platform. Read what leads me to a neutral stance for TECX stock.
Tectonic Therapeutic (TECX) announced the closing of its planned merger with AVROBIO (AVRO), along with a concurrent $130.7 private placement. Read more here.
NEW YORK, May 10, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed merger of AVROBIO, Inc. and Tectonic Therapeutic, Inc....
NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...
REDWOOD CITY, Calif., Nov. 12, 2021 -- Jasper Therapeutics, Inc. , a biotechnology company focused on hematopoietic cell transplant therapies, today announced results for the quarter ended... | November 12, 2021